BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 14211297)

  • 1. TARTRATE-INHIBITED ACID PHOSPHATASE IN BENIGN PROSTATIC HYPERTROPHY AND IN PROSTATIC CANCER.
    LANDBERG T
    Acta Chir Scand; 1964 Oct; 128():435-41. PubMed ID: 14211297
    [No Abstract]   [Full Text] [Related]  

  • 2. TARTRATE-INHIBITED ACID PHOSPHATASE IN BENIGN PROSTATIC HYPERTROPHY AND IN PROSTATIC CANCER.
    JACOBSSON K; LANDBERG T
    Acta Chir Scand; 1964 Apr; 127():415-26. PubMed ID: 14149644
    [No Abstract]   [Full Text] [Related]  

  • 3. [ATTEMPTED MEASUREMENT OF LABILE TARTRATE ACID PHOSPHATASE].
    MICHON L; BESSON R
    Acta Urol Belg; 1964 Jan; 32():86-7. PubMed ID: 14111386
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON BONE METASTASIS OF PROSTATIC CANCER. REVIEW OF 21 CASES].
    TSUCHIDA M; MORIAI N; KUBO T
    Nihon Seikeigeka Gakkai Zasshi; 1963 Sep; 37():447-66. PubMed ID: 14051883
    [No Abstract]   [Full Text] [Related]  

  • 5. THE VALUE OF SEROMUCOID ESTIMATION IN THE MANAGEMENT OF PROSTATIC DISEASE.
    CAMERON E; CAMPBELL A
    Br J Urol; 1964 Jun; 36():257-60. PubMed ID: 14191154
    [No Abstract]   [Full Text] [Related]  

  • 6. Ratio of serum tartrate-inhibitable acid phosphatase to total serum protein in benign prostatic hypertrophy and prostatic carcinoma.
    Petrovich G; Ursich-Jankovich J; Prijovich Z
    Clin Chem; 1992 Feb; 38(2):276-7. PubMed ID: 1371723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METASTATIC PROSTATIC CARCINOMA SIMULATING PRIMARY OSTEOGENIC SARCOMA.
    PENN I; SHNIER GJ
    J Coll Radiol Australas; 1964 Jun; 8():160-5. PubMed ID: 14173979
    [No Abstract]   [Full Text] [Related]  

  • 8. PROGNOSTICATION OF CARCINOMA OF THE PROSTATE METASTATIC TO THE SKELETON BY RADIOLOGICAL STUDIES.
    SCHIRMER HK; RICHARDS GJ
    J Urol; 1964 Dec; 92():714-20. PubMed ID: 14241206
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON THE BEHAVIOR OF SERUM ACID PHOSPHATASE IN DIFFERENT OSTEOPATHIES. (PRELIMINARY REPORT)].
    CZITOBER H; JESSERER H
    Klin Wochenschr; 1963 Nov; 41():1068-9. PubMed ID: 14098344
    [No Abstract]   [Full Text] [Related]  

  • 10. A NEW PITUITARY-INHIBITING COMPOUND IN THE TREATMENT OF PROSTATIC CANCER.
    NYLANDER G; TERNER N
    Urol Int; 1964; 17():129-45. PubMed ID: 14168016
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
    Fleischmann J; Catalona WJ; Fair WR; Heston WD; Menon M
    J Urol; 1983 Feb; 129(2):312-4. PubMed ID: 6187945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PROSTATIC CANCER, SYMPTOMATOLOGY AND DIAGNOSIS].
    AGUIRRE C
    Rev Mex Urol; 1963 Oct; 22():SUPPL:200-6. PubMed ID: 14103773
    [No Abstract]   [Full Text] [Related]  

  • 13. [VALUE OF THE DETERMINATION OF SERUM ACID PHOSPHATASE IN PROSTATIC CANCER. APROPOS OF 100 CASES].
    WEMEAU L; MAZEMAN E
    Lille Chir; 1964; 19():4-11. PubMed ID: 14152664
    [No Abstract]   [Full Text] [Related]  

  • 14. [THE VALUE OF BIOLOGICAL EXAMINATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATIC DISEASES].
    MICHON J
    Acta Urol Belg; 1964 Jan; 32():85. PubMed ID: 14111385
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE VALUE OF BIOLOGICAL EXAMINATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATIC DISEASES].
    BRENEZ J
    Acta Urol Belg; 1964 Jan; 32():100-3. PubMed ID: 14111370
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE VALUE OF BIOLOGICAL EXAMINATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATIC DISEASES].
    LAFRANCE L
    Acta Urol Belg; 1964 Jan; 32():98-9. PubMed ID: 14111388
    [No Abstract]   [Full Text] [Related]  

  • 17. HYPOCALCEMIA AND HYPOPHOSPHATEMIA ACCOMPANYING OSTEOBLASTIC METASTASES.
    RANDALL RE; LIRENMAN DS
    J Clin Endocrinol Metab; 1964 Dec; 24():1331-3. PubMed ID: 14243178
    [No Abstract]   [Full Text] [Related]  

  • 18. CARCINOMA ORIGINATING IN DUCTS SURROUNDING THE PROSTATIC URETHRA.
    ENDE N; WOODS LP; SHELLEY HS
    Am J Clin Pathol; 1963 Aug; 40():183-9. PubMed ID: 14060023
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of L-tartrate in determining prostatic serum acid phosphatase: a report of 514 cases.
    MATHES G; RICHMOND SG; SPRUNT DH
    Trans Southeast Sect Am Urol Assoc; 1955; (19th Meeting):58-65. PubMed ID: 13274458
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognosis and treatment of prostatic carcinoma].
    Klug W
    Zentralbl Chir; 1968 Mar; 93(10):362-6. PubMed ID: 5674208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.